Printer-friendly versionPrinter-friendly version

Hepatitis B, hepatitis C, and other blood-borne infections in healthcare workers

Rome, Italy, March 17-18, 2005

- Meeting Programme -

Thursday, March 17, 2005

Session 1   Opening and objectives

Chair: Vincenzo Puro and Nedret Emiroglu

09.00 - 09.20

  • Welcome
  • Introduction of the participants
  • Objectives of the meeting:
    1.To review the global epidemiology of blood-borne infections in healthcare workers;
    2.To evaluate the transmission of hepatitis B virus and hepatitis C virus as an occupational risk;
    3.To discuss primary and secondary prevention measures against hepatitis B virus and hepatitis C virus infections in healthcare workers; and
    4.To review the recommendations for HBV-, HCV-, or HIV-infected healthcare workers or (para)medical students.
  • Review of the meeting programme
  • Pre-meeting document 378 Kb (.pdf)

Session 2   Global epidemiology of hepatitis B and C virus infections in healthcare workers

Chair: Alessandro Zanetti and Peter Grob

09.20 - 09.55
Prevalence of HBV and HCV in healthcare workers 1073 Kb (.pdf)
Annarosa Floreani, Padua, Italy

09.55 - 10.35
Definitions: exposure-prone procedures, nosocomial infection, viral-load thresholds for HBV, HCV, and HIV infectivity 1222 Kb (.pdf)
Vincenzo Puro, Roma, Italy

10.35 - 11.10
Coffee break

11.10 - 11.45
Occupational fraction of HBV and HCV infections in healthcare workers globally 576 Kb (.pdf)
Annette Prüss-Üstün, Geneva, Switzerland

11.45 - 12.20
Risk assessment of occupational and nosocomial HBV / HCV infection by type of clinician and procedure 708 Kb (.pdf)
Lidia Proietti, Catania, Italy

12.05 - 13.35
Lunch

Session 3   Transmission of HBV and HCV as an occupational risk

Chair: Susan Goldstein and Paolo Bonanni

13.35 - 14.20
Transmission of blood-borne viruses in the healthcare setting 589 Kb (.pdf)
Gabriella De Carli, Roma, Italy

14.20 - 14.45 
Look-back (retrospective) studies 367 Kb (.pdf)
Vincenzo Puro, Roma, Italy

14.45 - 15.20 
Healthcare-related outbreaks of hepatitis B and C in the United States 469 Kb (.pdf)
Ian Williams, Atlanta, USA

15.20 - 15.50
Coffee break

Session 4   Primary and secondary prevention of HBV and HCV infections in healthcare workers

Chair: Antoon De Schryver and Steven Wiersma

15.50 - 16.20 
General precautionary measures 1590 Kb (.pdf)
Andreas Kopka, Glasgow, United Kingdom

16.20 - 16.45 
Post-exposure management of occupational exposure to blood-borne pathogens 494 Kb (.pdf)
Fortune Ncube, London, United Kingdom

16.45 - 17.10 
Co-infected healthcare workers 538 Kb (.pdf)
Yazdan Yazdanpanah, Tourcoing, France

17.10 - 17.35 
Should patients be tested before undergoing invasive procedures? 139 Kb (.pdf)
Johannes Hallauer, Berlin, Germany

Friday, March 18, 2005

Session 5   Recommendations for HBV-, HCV-, or HIV-positive healthcare workers and (para)medical students

Chair: Françoise Roudot-Thoraval and Daniel Lavanchy

09.00 – 10.00 
Feedback from the EASL study (Gunson et al., 2003) 397 Kb (.pdf)
Daniel Shouval, Jerusalem, Israel

10.00 - 10.35 
Current vaccination policies for healthcare workers, including booster policies, vaccination coverage, and serological testing 290 Kb (.pdf)
Antoon De Schryver, Gent, Belgium

10.35 - 11.00
Coffee break

11.00 - 11.35 
Quantitative HBV DNA measurements and the management of infected healthcare workers 782 Kb (.pdf)
Annemiek van der Eijk, Rotterdam, The Netherlands

11.35 - 12.05 
Inventory of current recommendations 469 Kb (.pdf)
Kirsty Roy, Glasgow, United Kingdom

12.05 - 14.15
Lunch

Session 6   Conclusions of the meeting

Chair: André Meheus and Daniel Shouval

14.15 - 16.00 
Presentation of the VHPB meeting conclusions, including discussion
David FitzSimons, Geneva, Switzerland

16.00
Close of the meeting

Tags: